PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 18, 2018Thorax62 citationsOpen Access

Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population

View Full Paper
KCKaman ChungOMOnno M. MetsPGPaul K. Gerke

Key Points

Key points are not available for this paper at this time.

Abstract

The Brock model shows high predictive discrimination of potentially malignant and benign nodules when validated in an unselected, heterogeneous clinical population. The high NPV may be used to decrease the number of nodule follow-up examinations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chung et al. (2018) studied this question.

synapsesocial.com/papers/69d9aee55e5bcb4e3b837a44https://doi.org/10.1136/thoraxjnl-2017-211372
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk of malignancy in pulmonary nodules: A validation study of four prediction models2015 · 193 citations
  2. 2The British Thoracic Society guidelines on the investigation and management of pulmonary nodules2015 · 749 citations
  3. 3Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach1988 · 22,933 citations
  4. 4Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening2011 · 11,228 citations
  5. 5Nested Case-Control Studies1994 · 307 citations